密件抄送的临床试验
总计1419个结果
-
Novartis Pharmaceuticals终止骨髓性白血病美国, 德国, 比利时, 意大利, 西班牙, 大韩民国, 巴西, 日本, 澳大利亚, 捷克共和国
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
Bristol-Myers Squibb终止
-
Sun Yat-sen UniversityXiangya Hospital of Central South University; Nanfang Hospital of Southern Medical University; Third Affiliated Hospital, Sun Yat-Sen University招聘中
-
M.D. Anderson Cancer CenterArray BioPharma终止
-
M.D. Anderson Cancer Center完全的
-
Gruppo Italiano Malattie EMatologiche dell'Adulto完全的
-
Gruppo Italiano Malattie EMatologiche dell'Adulto完全的
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)未知
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
EDDC (Experimental Drug Development Centre), A*STAR...Chiltern International Inc.撤销Ph+ 急性淋巴细胞白血病 (Ph+ALL) | Ph- 急性淋巴细胞白血病 (Ph-ALL) | 慢性粒细胞白血病加速期 (CML-AP, Ph+) | 慢性粒细胞白血病急变 (CML-BC, Ph+)美国, 新加坡
-
University Hospital, Bordeaux完全的白血病,骨髓性,慢性,BCR-ABL 阳性法国
-
Gruppo Italiano Malattie EMatologiche dell'AdultoEuropean Leukemia Net; CML Advocates Network未知
-
Institut BergoniéNovartis终止
-
Affiliated Hospital of Nantong University招聘中
-
University of Maryland, BaltimoreNational Cancer Institute (NCI)完全的
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
Theralase® Technologies Inc.University Health Network, Toronto; Pharma eMarket招聘中
-
Seoul St. Mary's HospitalMinistry of Health & Welfare, Korea未知
-
Uppsala UniversityKarolinska University Hospital; Uppsala University Hospital完全的医疗质量 | Health Care Evaluation瑞典
-
UCSI UniversityUniversity of Malaya; Ampang Hospital, Malaysia完全的
-
Novartis Pharmaceuticals完全的
-
Novartis Pharmaceuticals完全的